Mitotane
(Information from www.ctlabs.co.uk) The adrenolytic agent Mitotane (o,p'-DDD) used for the treatment of inoperable adrenocortical carcinoma. Its cytostatic effect appears to depend on the maintenance of adequate plasma levels, and encouraging results have been acheived when drug dosing has been based on pharmacological monitoring. Clinical indication for request: therapeutic drug monitoring.
| Tube | 04 (EP) - EDTA Plasma |
|---|---|
| ID | Tests&Tubes0217 |
| Turn Around | Turnaround time stated by Cardiff: 7 days. |
| Send to | Blood Sciences LGI (Test referred to: Cardiff toxicology lab) |
| Contact | For further details please contact Leeds Pathology customer services: leedsth-tr.pathologycustomerservice@nhs.net. |
| Advice | Full information on all referred tests can be found on the referred tests information database, EQMS reference BSF2REC17003. |
| Collection Con | Please collect EDTA blood. Serum gel tubes are not suitable. Instructions to lab: centrifuge sample, separate and freeze plasma. Minimum volume: 1 mL plasma. |
| Sample REQ | Blood |
| Ref. Range Notes | Therapeutic range: 14 - 20 mg/L |
| Units | mg/L |
| Telepath | No code. Book in as PROB1L (comment NRSOT) & SA1R |
